The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16225593.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The study of pharmacogenetics will optimize the use of systemic therapies in dermatology. Directed prescription of azathioprine dependent on phenotypic expression of the thiopurine methyltransferase gene is now accepted practice. To some extent other, older drugs have been neglected. We look at the role that pharmacogenetics could play in the use of methotrexate for psoriasis, focusing on known polymorphisms in the folate metabolic pathway.
Medical subject headings
- Immunosuppressive Agents
- Methotrexate
- Psoriasis